Venus Medtech (Hangzhou) Inc. (VMTHF)
OTCMKTS · Delayed Price · Currency is USD
0.4219
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Venus Medtech (Hangzhou) Revenue
Venus Medtech (Hangzhou) had revenue of 187.14M CNY in the half year ending June 30, 2025, a decrease of -26.79%. This brings the company's revenue in the last twelve months to 427.25M, down -8.41% year-over-year. In the year 2024, Venus Medtech (Hangzhou) had annual revenue of 470.83M, down -4.18%.
Revenue (ttm)
427.25M CNY
Revenue Growth
-8.41%
P/S Ratio
2.71
Revenue / Employee
706.20K CNY
Employees
605
Market Cap
161.33M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 470.83M | -20.54M | -4.18% |
| Dec 31, 2023 | 491.37M | 84.91M | 20.89% |
| Dec 31, 2022 | 406.46M | -9.40M | -2.26% |
| Dec 31, 2021 | 415.86M | 139.82M | 50.65% |
| Dec 31, 2020 | 276.05M | 42.78M | 18.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
Venus Medtech (Hangzhou) News
- 10 months ago - Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations - PRNewsWire
- 1 year ago - Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study - PRNewsWire
- 1 year ago - Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S. - PRNewsWire
- 2 years ago - Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval - PRNewsWire
- 2 years ago - Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023 - PRNewsWire